Red Door Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Red Door Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,330	Closed	-$260K	–	167
2021 Q4	$260K	Sell	2,330 -96	-4%	-$11.6K	0.09%	141
2021 Q3	$305K	Hold	2,426	–	–	0.12%	125
2021 Q2	$328K	Buy	+2,426	New	+$319K	0.13%	115
2020 Q3	–	Sell	-1,299	Closed	-$145K	–	440
2020 Q2	$145K	Hold	1,299	–	–	0.11%	112
2020 Q1	$100K	Buy	+1,299	New	+$115K	0.09%	120

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Red Door Wealth Management's XBI Position: Q1 2022 in Review

Red Door Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2022, closing a stake of 2,330 shares — an estimated $260K sold.

Red Door Wealth Management first reported a position in XBI in Q1 2020 and held it in 5 quarters. The position peaked at $328K in Q2 2021. 703 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

Red Door Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2022 after selling out during the quarter.
Red Door Wealth Management sold 2,330 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $260K.
Red Door Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and held it in 5 quarters.
Red Door Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $328K in Q2 2021.
703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on Red Door Wealth Management's 13F filing for Q1 2022, filed 20 Apr 2022.